Gene News and Research

Latest Gene News and Research

Cellular Origins partners with ScaleReady to simplify, standardise, and automate cell therapy manufacturing

Cellular Origins a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs).

From Cellular Origins 11 May 2023

Are quaternary ammonium compounds associated with adverse environmental and health outcomes?

Researchers presented an overview of quaternary ammonium compounds and their environmental and human health concerns.

11 May 2023

Study extends understanding of m6A modification as biological pathway underlying atrial fibrillation

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Numerous single nucleotide polymorphisms (SNPs) have been identified as genetic contributors to atrial fibrillation (AF).

11 May 2023

Researchers show the effect of SARS-CoV-2 infection on somatosensory abnormalities in a hamster model

In a recent article published in the journal Science Immunology, researchers in the United States performed a longitudinal cohort study in a golden hamster model to investigate the sensory-altering mechanisms induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection compared to an influenza A virus (IAV).

11 May 2023

New approaches to promote healthspan from an epigenetic perspective

A new review paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 8, entitled, "How can we modulate aging through nutrition and physical exercise? An epigenetic approach."

10 May 2023

Personalizing transcranial magnetic stimulation for the treatment of depression

Artificial intelligence. Gene editing. mRNA vaccines. It's safe to say the past few decades have felt like the next big wave of medicine. However, what continues to be needed in virtually every field is a personalized approach to care.

10 May 2023

Silenced p16 gene can drive colorectal cancer progression

Colorectal cancer is the fourth most common and second deadliest cancer. How colorectal cancer develops is not well understood, but a team led by researchers at Baylor College of Medicine reports in the Journal of Experimental & Clinical Cancer Research that silencing the gene p16, even though the DNA itself does not change, can drive colorectal cancer progression in animal models.

10 May 2023

Leveraging proteomics datasets to discover potential therapeutic targets for cancer patients

A new research perspective was published in Oncotarget's Volume 14 on May 4, 2023, entitled, "Using cancer proteomics data to identify gene candidates for therapeutic targeting."

10 May 2023

Menthol inhalation improves cognitive ability in animal models of Alzheimer's disease

Researchers from Cima University of Navarra (Spain) have shown in animal models of Alzheimer's disease that inhaling menthol improves cognitive ability.

10 May 2023

Is wind spreading urban malaria?

Researchers proposed that the wind may facilitate mosquito transmission over long distances.

10 May 2023

An outdated tracking system is a key factor in Texas’ foster care shortcomings

The decades-old system Texas foster care officials use to track and monitor the health records of the nearly 20,000 children in their custody is both outdated and unreliable — so much so, advocates say, that children have been harmed or put at risk.

10 May 2023

MGI launches overseas production line of DNBSEQ-G400* sequencer in Latvia

Riga, Latvia, 8 May 2023 – LATVIA MGI TECH, SIA, ("MGI Latvia") a subsidiary of MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, today announced the official opening of its large-scale production line in Latvia. As MGI's largest regional hub for the European market, the facility based in Riga will see assembly and production of DNBSEQ-G400* gene sequencing instruments and HotMPS** reagents.

From MGI 10 May 2023

MGI empowers the completion of nearly 60,000 samples for the million microbiome of humans project

Through the Million Microbiome of Humans Project, MGI Tech is building a comprehensive microbiome database to support global health and research initiatives.

From MGI 10 May 2023

Evonetix delivers first chip-synthesized DNA to the University of Cambridge

Evonetix, the company bringing semiconductor technology to DNA synthesis, today announced that DNA synthesized using its unique semiconductor chip technology was delivered to the Department of Chemical Engineering and Biotechnology at the University of Cambridge.

From Evonetix 10 May 2023

Gene News and Research

Latest Gene News and Research

Cellular Origins partners with ScaleReady to simplify, standardise, and automate cell therapy manufacturing

Are quaternary ammonium compounds associated with adverse environmental and health outcomes?

Study extends understanding of m6A modification as biological pathway underlying atrial fibrillation

Researchers show the effect of SARS-CoV-2 infection on somatosensory abnormalities in a hamster model

New approaches to promote healthspan from an epigenetic perspective

Personalizing transcranial magnetic stimulation for the treatment of depression

Silenced p16 gene can drive colorectal cancer progression

Leveraging proteomics datasets to discover potential therapeutic targets for cancer patients

Menthol inhalation improves cognitive ability in animal models of Alzheimer's disease

Is wind spreading urban malaria?

An outdated tracking system is a key factor in Texas’ foster care shortcomings

MGI launches overseas production line of DNBSEQ-G400* sequencer in Latvia

MGI empowers the completion of nearly 60,000 samples for the million microbiome of humans project

Evonetix delivers first chip-synthesized DNA to the University of Cambridge

New SNAP approach to customizing T cell-based immunotherapies

Same genetic defects shared by some patients with motor neuron disease and frontotemporal dementia

Baylor scientists link MRTFB gene variants with novel neurodevelopmental disorder

Different statin drugs exert different effects on COVID-19 patients

Study may provide new avenues for addressing somatosensory symptoms of long COVID

Novel fluorescent probe reveals constant conversion rate of endolysosomes

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research